Analyst Price Targets — ALDX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 8, 2025 4:49 pm | Clara Dong | Jefferies | $7.00 | $5.62 | TheFly | Aldeyra price target raised to $7 from $6 at Jefferies |
| October 3, 2024 9:30 am | Justin Kim | Oppenheimer | $12.00 | $5.14 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Aldeyra Therapeutics (ALDX) |
| April 3, 2024 7:08 am | Justin Kim | Oppenheimer | $10.00 | $3.55 | StreetInsider | Oppenheimer Upgrades Aldeyra Therapeutics (ALDX) to Outperform |
| April 2, 2024 6:08 am | Matt Caufield | H.C. Wainwright | $10.00 | $3.27 | StreetInsider | H.C. Wainwright Reinstates Aldeyra Therapeutics (ALDX) at Buy |
Latest News for ALDX
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Iovance Biotherapeutics (IOVA) have performed compared to their sector so far this year.
The consensus price target hints at a 79.3% upside potential for Aldeyra Therapeutics (ALDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate virtually in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference.…
The consensus price target hints at a 65.8% upside potential for Aldeyra Therapeutics (ALDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is how Aldeyra Therapeutics, Inc. (ALDX) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALDX.
U.S. House Trading
No House trades found for ALDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.